Five Years of Cancer Drug Approvals: Innovation, Efficacy, and Costs

JAMA Oncol. 2015 Jul;1(4):539-40. doi: 10.1001/jamaoncol.2015.0373.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents / economics*
  • Antineoplastic Agents / therapeutic use*
  • Cost-Benefit Analysis
  • Device Approval*
  • Diffusion of Innovation*
  • Drug Costs*
  • Humans
  • Inflation, Economic
  • Time Factors
  • Treatment Outcome
  • United States
  • United States Food and Drug Administration

Substances

  • Antineoplastic Agents